FDA Grants Clearance to BD Molecular Test
FDA has granted premarket notification (510(k)) clearance to BD for its newly developed molecular test for detecting harmful intestinal bacteria causing infectious diarrhea.
Read More
Search Results for: liver disease
Companies Announce PCR Middleware Collaboration
The agreement consists of a strategic expertise exchange between UgenTec and Hamann Laborautomation.
Read MoreBeckman Coulter Diagnostics Expands Chemistry Menu
Beckman Coulter Diagnostics, along with partner Diazyme Laboratories, has announced FDA premarket notification (510(k)) clearance of a new procalcitonin assay.
Read More
Seattle Children’s Opens Precision Medicine Clinical Trial to IBD, Bone Marrow Transplant Patients
The Precision Diagnostics in Inflammatory Bowel Disease, Cellular Therapy, and Transplantation (PREDICT) trial is expected to provide clinicians new information about why inflammatory bowel disease arises in children, allowing them to tailor treatment plans to each patient.
Read More
HEOR for Diagnostics
The clinical lab community needs a shared vision for calculating the value of diagnostic testing.
Read More